We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · September 27, 2022

Association of Plasma Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels With Disability Worsening in MS

Multiple Sclerosis (Houndmills, Basingstoke, England)


Additional Info

Disclosure statements are available on the authors' profiles:

Multiple Sclerosis (Houndmills, Basingstoke, England)
Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis
Mult. Scler. 2022 Oct 01;28(11)1685-1696, A Pauwels, J Van Schependom, L Devolder, A Van Remoortel, G Nagels, M Bjerke, MB D'hooghe

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading